ArticleBiomarker research2023

Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors.

Dingwei Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.